How Can Quality of Dementia Care Be Measured? The Development of Clinical Quality Indicators for an Australian Pilot Dementia Registry.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 12 5 2020
medline: 11 5 2021
entrez: 12 5 2020
Statut: ppublish

Résumé

A clinical quality registry (CQR) for dementia provides benefits to those living with dementia and their carers by improving the quality and experience of care through benchmarking and monitoring patient outcomes. CQRs use data collected to form clinical quality indicators (CQIs) through which variations in clinical processes and outcomes between different services and jurisdictions can be highlighted. This modified Delphi study aimed to develop CQIs for a pilot Australian CQR for dementia and mild cognitive impairment. These CQIs are based on evidence, patient and caregiver experience, and clinician perspectives across the trajectory of care from diagnosis to end-of-life. An initial list of indicators from existing dementia registries, academic literature, and clinical practice guidelines was synthesized. A working group of clinicians and registry experts further refined these indicators. A panel of experts comprised of a consumer, a carer, clinicians, consumer organization representatives, and academics. The experts participated in three phases of the modified Delphi study: 1) online survey for scoring importance and validity, 2) a one-day face-to-face discussion, and 3) final survey round to assess importance, validity, and feasibility. The panel assessed 33 CQIs and confirmed a final set of 18 indicators. The CQIs mapped to the domains of quality of diagnosis, quality of management, access to services and supports, and potentially preventable complications. These CQIs will be tested initially in memory clinics and inform the data collection processes for the Australia Dementia Network Registry (ADNet). A dementia CQR is fundamental to ongoing monitoring and development of good quality and consistent care across Australia.

Sections du résumé

BACKGROUND
A clinical quality registry (CQR) for dementia provides benefits to those living with dementia and their carers by improving the quality and experience of care through benchmarking and monitoring patient outcomes. CQRs use data collected to form clinical quality indicators (CQIs) through which variations in clinical processes and outcomes between different services and jurisdictions can be highlighted.
OBJECTIVE
This modified Delphi study aimed to develop CQIs for a pilot Australian CQR for dementia and mild cognitive impairment. These CQIs are based on evidence, patient and caregiver experience, and clinician perspectives across the trajectory of care from diagnosis to end-of-life.
METHODS
An initial list of indicators from existing dementia registries, academic literature, and clinical practice guidelines was synthesized. A working group of clinicians and registry experts further refined these indicators. A panel of experts comprised of a consumer, a carer, clinicians, consumer organization representatives, and academics. The experts participated in three phases of the modified Delphi study: 1) online survey for scoring importance and validity, 2) a one-day face-to-face discussion, and 3) final survey round to assess importance, validity, and feasibility.
RESULTS
The panel assessed 33 CQIs and confirmed a final set of 18 indicators. The CQIs mapped to the domains of quality of diagnosis, quality of management, access to services and supports, and potentially preventable complications. These CQIs will be tested initially in memory clinics and inform the data collection processes for the Australia Dementia Network Registry (ADNet).
CONCLUSION
A dementia CQR is fundamental to ongoing monitoring and development of good quality and consistent care across Australia.

Identifiants

pubmed: 32390616
pii: JAD191044
doi: 10.3233/JAD-191044
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

923-936

Auteurs

Darshini Ayton (D)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Madeleine Gardam (M)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Stephanie Ward (S)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, NSW, Australia.

Henry Brodaty (H)

Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, NSW, Australia.

Elizabeth Pritchard (E)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Arul Earnest (A)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Karolina Krysinska (K)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Jane Banaszak-Holl (J)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

John McNeil (J)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Susannah Ahern (S)

Department of Epidemiology and Preventive Medicine, Public Health and Preventive Medicine, Monash University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH